How We Treat Localized Rectal Cancer-An Institutional Paradigm for Total Neoadjuvant Therapy.

CRT TNT chemoradiotherapy microsatellite instability mismatch-repair-deficiency organ-sparing radiotherapy rectal cancer total neoadjuvant therapy

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
21 Nov 2022
Historique:
received: 13 10 2022
revised: 15 11 2022
accepted: 16 11 2022
entrez: 26 11 2022
pubmed: 27 11 2022
medline: 27 11 2022
Statut: epublish

Résumé

Total neoadjuvant therapy (TNT)-the neoadjuvant employment of radiotherapy (RT) or chemoradiation (CRT) as well as chemotherapy (CHT) before surgery-may lead to increased pathological complete response (pCR) rates as well as a reduction in the risk of distant metastases in locally advanced rectal cancer. Furthermore, increased response rates may allow organ-sparing strategies in a growing number of patients with low rectal cancer and upfront immunotherapy has shown very promising early results in patients with microsatellite instability (MSI)-high/mismatch-repair-deficient (dMMR) tumors. Despite the lack of a generally accepted treatment standard, we strongly believe that existing data is sufficient to adopt the concept of TNT and immunotherapy in clinical practice. The treatment algorithm presented in the following is based on our interpretation of the current data and should serve as a practical guide for treating physicians-without any claim to general validity.

Identifiants

pubmed: 36428801
pii: cancers14225709
doi: 10.3390/cancers14225709
pmc: PMC9688120
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

Br J Surg. 2009 Nov;96(11):1348-57
pubmed: 19847867
J Clin Oncol. 2019 Dec 1;37(34):3212-3222
pubmed: 31150315
Lancet. 2009 Mar 7;373(9666):811-20
pubmed: 19269519
Int J Colorectal Dis. 2001 Sep;16(5):298-304
pubmed: 11686527
Insights Imaging. 2020 Sep 3;11(1):100
pubmed: 32880782
Nat Med. 2020 Apr;26(4):566-576
pubmed: 32251400
Radiat Oncol. 2020 Nov 10;15(1):262
pubmed: 33172475
J Am Coll Radiol. 2017 May;14(5S):S234-S244
pubmed: 28473079
J Gastrointest Oncol. 2017 Aug;8(4):625-628
pubmed: 28890811
Colorectal Dis. 2012 Mar;14(3):294-8
pubmed: 21899712
Expert Rev Gastroenterol Hepatol. 2016 Sep;10(9):1011-25
pubmed: 27152870
N Engl J Med. 2020 Dec 3;383(23):2207-2218
pubmed: 33264544
Dis Colon Rectum. 2012 Dec;55(12):1220-8
pubmed: 23135579
Eur J Med Res. 2015 Jan 14;20:4
pubmed: 25586770
Jpn J Clin Oncol. 2018 Jul 01;48(7):625-632
pubmed: 29788392
Clin Radiol. 2014 Jun;69(6):619-23
pubmed: 24581964
J Surg Oncol. 2014 Nov;110(6):739-44
pubmed: 24962179
Lancet Gastroenterol Hepatol. 2022 Jan;7(1):38-48
pubmed: 34688374
J Clin Oncol. 2016 Nov 1;34(31):3773-3780
pubmed: 27432930
J Clin Oncol. 2022 Aug 10;40(23):2546-2556
pubmed: 35483010
Radiologe. 2019 Dec;59(Suppl 1):46-50
pubmed: 31616956
BMC Cancer. 2015 Oct 23;15:767
pubmed: 26497495
J Clin Oncol. 2008 Jan 10;26(2):303-12
pubmed: 18182672
Ann Surg. 2004 Oct;240(4):711-7; discussion 717-8
pubmed: 15383798
Mol Clin Oncol. 2019 May;10(5):555-559
pubmed: 30967950
Ann Oncol. 2014 Apr;25(4):858-863
pubmed: 24667718
Ann Surg Oncol. 2015 Nov;22(12):3873-80
pubmed: 26198074
Int J Colorectal Dis. 2010 Mar;25(3):359-68
pubmed: 20012295
J Clin Oncol. 2011 Aug 10;29(23):3163-72
pubmed: 21747092
J Clin Oncol. 2011 Dec 10;29(35):4633-40
pubmed: 22067400
J Clin Oncol. 2019 Nov 20;37(33):3111-3123
pubmed: 31593484
Int J Colorectal Dis. 2022 Apr;37(4):855-868
pubmed: 35279746
Br J Surg. 2018 Dec;105(13):1844-1852
pubmed: 30079958
Br J Surg. 2019 Sep;106(10):1298-1310
pubmed: 31216064
Lancet Gastroenterol Hepatol. 2017 Jul;2(7):501-513
pubmed: 28479372
Eur J Surg Oncol. 2014 Apr;40(4):469-75
pubmed: 24439446
Lancet Oncol. 2021 Jan;22(1):29-42
pubmed: 33301740
Colorectal Dis. 2010 Oct;12(10):977-86
pubmed: 19438885
Lancet Oncol. 2015 Aug;16(8):957-66
pubmed: 26187751
Ann Surg Oncol. 2010 Mar;17(3):838-45
pubmed: 20012700
Radiother Oncol. 2021 Nov;164:268-274
pubmed: 34653526
Radiology. 2013 Aug;268(2):330-44
pubmed: 23882096
Clin Cancer Res. 2020 Jul 1;26(13):3271-3279
pubmed: 32144135
Eur J Cancer. 2009 May;45(7):1175-1183
pubmed: 19128956
N Engl J Med. 2001 Aug 30;345(9):638-46
pubmed: 11547717
Insights Imaging. 2021 Aug 9;12(1):114
pubmed: 34373961
Lancet Oncol. 2015 Aug;16(8):919-27
pubmed: 26156652
Br J Cancer. 2017 Jun 6;116(12):1513-1519
pubmed: 28449006
J Clin Oncol. 2012 Jun 1;30(16):1926-33
pubmed: 22529255
Support Care Cancer. 2021 Dec;29(12):7249-7258
pubmed: 34296335
Dis Colon Rectum. 2017 Jun;60(6):577-585
pubmed: 28481851
N Engl J Med. 2022 Jun 23;386(25):2363-2376
pubmed: 35660797
Eur Radiol. 2018 Apr;28(4):1465-1475
pubmed: 29043428
J Clin Oncol. 2008 Jan 20;26(3):368-73
pubmed: 18202411
Dis Colon Rectum. 2010 May;53(5):761-70
pubmed: 20389210
Lancet Oncol. 2021 May;22(5):702-715
pubmed: 33862000

Auteurs

Falk Roeder (F)

Department of Radiation Oncology, Paracelsus Medical University Salzburg, 5020 Salzburg, Austria.

Sabine Gerum (S)

Department of Radiation Oncology, Paracelsus Medical University Salzburg, 5020 Salzburg, Austria.

Stefan Hecht (S)

Department of Radiology, Paracelsus Medical University Salzburg, 5020 Salzburg, Austria.

Florian Huemer (F)

Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute-Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Center for Clinical Cancer and Immunology Trials (CCCIT), Cancer Cluster Salzburg, Paracelsus Medical University Salzburg, 5020 Salzburg, Austria.

Tarkan Jäger (T)

Department of Visceral and Thoracic Surgery, Paracelsus Medical University Salzburg, 5020 Salzburg, Austria.

Reinhard Kaufmann (R)

Department of Radiology, Paracelsus Medical University Salzburg, 5020 Salzburg, Austria.

Eckhard Klieser (E)

Institute of Pathology, Paracelsus Medical University Salzburg, Cancer Cluster Salzburg, 5020 Salzburg, Austria.

Oliver Owen Koch (OO)

Department of Visceral and Thoracic Surgery, Paracelsus Medical University Salzburg, 5020 Salzburg, Austria.

Daniel Neureiter (D)

Institute of Pathology, Paracelsus Medical University Salzburg, Cancer Cluster Salzburg, 5020 Salzburg, Austria.

Klaus Emmanuel (K)

Department of Visceral and Thoracic Surgery, Paracelsus Medical University Salzburg, 5020 Salzburg, Austria.

Felix Sedlmayer (F)

Department of Radiation Oncology, Paracelsus Medical University Salzburg, 5020 Salzburg, Austria.

Richard Greil (R)

Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute-Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Center for Clinical Cancer and Immunology Trials (CCCIT), Cancer Cluster Salzburg, Paracelsus Medical University Salzburg, 5020 Salzburg, Austria.

Lukas Weiss (L)

Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute-Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Center for Clinical Cancer and Immunology Trials (CCCIT), Cancer Cluster Salzburg, Paracelsus Medical University Salzburg, 5020 Salzburg, Austria.

Classifications MeSH